A randomized, placebo controlled trial of milk products for prevention of gout flares

Not Applicable

Completed

• Conditions: Musculoskeletal - Other muscular and skeletal disorders; Gout

• Registration Number: ACTRN12609000479202
• Lead Sponsor: actoPharma Consortium

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2009-06-17
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 120

Inclusion Criteria

1.Diagnosis of gout (based on American College of Rheumatology [ACR]criteria)
2.At least two gout flares in the last four months
3.Able to provide written informed consent
4.Age 18 years and above

Exclusion Criteria

1.Lactose intolerance
2.Severe renal impairment (glomerular filtration rate [GFR]<30)

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Frequency of gout flares (requiring treatment), using a gout flare diary[At one, two and three months after the commencement of treatment]

Secondary Outcome Measures

Name	Time	Method
Severity of flare pain (10-point Likert scale)[At one, two and three months after the commencement of treatment];Patient global assessment using a 5-point Likert scale[At one, two and three months after the commencement of treatment];Serum urate concentration (blood test, standard biochemistry assay)[At one, two and three months after the commencement of treatment]